Item 7.01 of Form 8-K, including the accompanying exhibit, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

 

The Company is holding its 2008 Annual Meeting of Stockholders beginning at 10 a.m. on July 2, 2008. A copy of management’s slide presentation for the meeting is attached hereto as Exhibit 99.1.

 

Item 9.01

 

Financial Statements and Exhibits.

 

 

 

(d)

 

Exhibits

 

 

 

99.1

 

Management’s Slide Presentation for the Company’s 2008 Annual Meeting of Stockholders*

 

* Such Exhibit is being “furnished” (not filed) pursuant to Item 7.01 of the Current Report on Form 8-K.

 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

REGENERX BIOPHARMACEUTICALS, INC.

 

By:

   /s/ J.J. FINKELSTEIN

 

 

 

 

 

   J.J. Finkelstein

 

 

   President and Chief Executive Officer

 

Date: July 2, 2008

 


 

EXHIBIT INDEX

 

Exhibit

 

 

Number

 

Description

99.1

 

Management’s Slide Presentation for the Company’s 2008 Annual Meeting of Stockholders*

 

* Such Exhibit is being “furnished” (not filed) pursuant to Item 7.01 of the Current Report on Form 8-K.